Tianqi Xu

20PUBLICATIONS
28CO-AUTHORS
Molecular targetsAerospace structuresApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)GlycoconjugatesMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 31, 2026
Imaging of ROR1 expression in tumors using radiolabeled affibody molecules.

|May 13, 2023
Radionuclide Therapy of HER2-Expressing Xenografts Using [177Lu]Lu-ABY-027 Affibody Molecule Alone and in Combination with Trastuzumab.

Yongsheng Liu, Tianqi Xu, Anzhelika Vorobyeva

|Feb 11, 2023
Feasibility of Co-Targeting HER3 and EpCAM Using Seribantumab and DARPin-Toxin Fusion in a Pancreatic Cancer Xenograft Model.

Tianqi Xu, Alexey Schulga, Elena Konovalova

|Sep 23, 2022
Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3.

Maryam Oroujeni, Ekaterina A Bezverkhniaia, Tianqi Xu

|Aug 26, 2022
Experimental HER2-Targeted Therapy Using ADAPT6-ABD-mcDM1 in Mice Bearing SKOV3 Ovarian Cancer Xenografts: Efficacy and Selection of Companion Imaging Counterpart.

Javad Garousi, Tianqi Xu, Yongsheng Liu

|Jul 27, 2022
Preclinical Evaluation of a New Format of 68Ga- and 111In-Labeled Affibody Molecule ZIGF-1R:4551 for the Visualization of IGF-1R Expression in Malignant Tumors Using PET and SPECT.

Yongsheng Liu, Shengze Yu, Tianqi Xu

Pageof 4

Frequent Collaborators

19 joint publications

Anna Orlova

19 joint publications

Vladimir Tolmachev

17 joint publications

Anzhelika Vorobyeva

10 joint publications

Torbjörn Gräslund